검색어 : 통합검색[006.6]
총 4,141건 중 1,000건 출력
, 14/100 페이지
-
131
- Systemic Disease Impacts CNS Disease Control After SRS in Patients with Breast Cancer Brain Metastases (P1-6.006)
- Schick, Alex; Hardy, Sara; Strawderman, Myla; Zheng, Dandan; Cummings, Michael; Milano, Michael; Magnuson, Allison; Behr, Jacqueline; Sammons, Sarah; Usuki, Kenneth; Mohile, Nimish; O’Regan, Ruth; Anders, Carey; Hicks, David; Hemminger, Lauryn; Dhakal, Ajay; University of Rochester School of Medicine & Dentistry; University of Rochester Medical Center; University of Rochester Medical Center; University of Rochester Medical Center; University of Rochester Medical Center; University of Rochester Medical Center; University of Rochester Medical Center; University of Rochester Medical Center; Dana-Farber Cancer Institute; University of Rochester Medical Center; University of Rochester Medical Center; University of Rochester Medical Center; Duke Cancer Institute; University of Rochester Medical Center; University of Rochester Medical Center; University of Rochester Medical Center; (Neurology, v.104, 2025, pp.1522)
-
132
- Early Impact of Natalizumab Switch to Moderate Versus High Efficacy Disease Modifying Therapy in Clinical Practice (S6.006)
- Hersh, Carrie; Harris, Haleigh; Conway, Devon; Hua, Le; Lou Ruvo Center for Brain Health Las Vegas NV United States; Lou Ruvo Center for Brain Health Las Vegas NV United States; Mellen Center for MS Treatment and Research, Cleveland Clinic Cleveland OH United States; Lou Ruvo Center for Brain Health Las Vegas NV United States; (Neurology, v.92, 2019, pp.S6.006)
-
133
- A Teleintervention Program for Multiple Sclerosis (MS) Mobility: Exercise with Transcranial Direct Current Stimulation (tDCS) (P18-6.006)
- Pilloni, Giuseppina; Moffat, Marilyn; Krupp, Lauren; Charvet, Leigh; Neurology, NYU Grossman School of Medicine; Physical Therapy, NYU; Neurology, NYU Langone Health; Neurology, NYU Grossman School of Medicine; (Neurology, v.98, 2022, pp.3290)
-
134
- Tetramethylpyrazine Analogue T-006 Exerts Neuroprotective Effects against 6-Hydroxydopamine-Induced Parkinson’s Disease <i>In Vitro</i> and <i>In Vivo</i>
- Zhou, Hefeng; Shao, Min; Yang, Xuanjun; Li, Chuwen; Cui, Guozhen; Gao, Cheng; Di, Lijun; Zhong, Hanbing; Wang, Yuqiang; Zhang, Zaijun; Lee, Simon Ming-Yuen; Department of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, China; Department of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, China; State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau, China; Key Laboratory of Molecular Target & Clinical Pharmacology, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, China; Department of Bioengineering, Zhuhai Campus of Zunyi Medical University, Zhuhai, China; State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau, China; Cancer Center, Faculty of Health Sciences, University of Macau, Macau, China; Department of Biology, South University of Science and Technology, Shenzhen, China; Institute of New Drug Research, College of Pharmacy, Jinan University, Guangzhou, China; Institute of New Drug Research, College of Pharmacy, Ji; (Oxidative medicine and cellular longevity, v.2019, 2019, pp.1-14)
-
135
- SuO006TWO MAJOR INSULIN RESISTANCE GENES (SIRT1 AND SIRT6) ARE ASSOCIATED WITH CONCENTRIC LEFT VENTRICULAR HYPERTROPHY IN END STAGE KIDNEY DISEASE
- Spoto Belinda; Testa Alessandra; Parlongo Rosa M; Sanguedolce Maria C; D' Arrigo Graziella; Tripepi Giovanni; Mallamaci Francesca; Zoccali Carmine; ; (Nephrology Dialysis Transplantation, v.30, 2015, pp.iii45-iii46)
-
136
- Cannabis Use Disorder in Multiple Sclerosis: Characterization of a National Sample of Patients Seeking Treatment (P2-6.006)
- Pehel, Shayna; Ko, Timothy; Fernandez, Luis; Kreisberg, Erica; Lustberg, Matthew; Pilloni, Giuseppina; Charvet, Leigh; NYU Grossman School of Medicine; NYU Grossman School of Medicine; NYU Grossman School of Medicine; NYU Grossman School of Medicine; NYU Grossman School of Medicine; NYU Grossman School of Medicine; NYU Grossman School of Medicine; (Neurology, v.102, 2024, pp.3683)
-
137
- P-006 The use of iv tpa beyond 6 hours from last known normal: data from the real world
- Hedayat, H; Binning, M; Veznedaroglu, E; Budzik, R; English, J; Baxter, B; Bartolini, B; Liebeskind, D; Krajina, A; Gupta, R; Nogueira, R; 1Neurosurgery, Drexel Neurosciences Institute, Philadelphia, PA; 1Neurosurgery, Drexel Neurosciences Institute, Philadelphia, PA; 1Neurosurgery, Drexel Neurosciences Institute, Philadelphia, PA; 2Neuroradiology, Riverside Methodist Hospital/Ohio Health Research Institute, Columbus, OH; 3Interventional Neurology, California Pacific Medical Center, San Francisco, CA; 4Neuroradiology, Erlanger Hospital, Chattanooga, TN; 5Interventional Neuroradiology, La Pitié Salpé é trié é è re, Paris, France; 6Vascular Neurology and Neuroimaging (Core Lab), University of California Los Angeles, Los Angeles, CA; 7Interventional Neuroradiology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic; 8Interventional Neurology, Wellstar Health System, PhiladelphiaMarietta, GA; 9Interventional Neuroradiology, Grady Memorial Hospit; (Journal of neurointerventional surgery, v.9, 2017, pp.A24-A25)
-
138
- Olfactory Dysfunction as an Indicator of Cognitive and Motor Impairment Severity in Huntington’s Disease (P6-3.006)
- Zadegan, Shayan; Feik, Madilyn; Coco, Hanna; Liang, Andi; Ramirez, Frank; Murillas, Jorge Patino; Rocha, Natalia Pessoa; Furr-Stimming, Erin; Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth); The University of Texas Health Science Center at Houston (UTHealth); The University of Texas Health Science Center at Houston (UTHealth); Washington University in St Louis, Department of Neurology; The University of Texas Health Science Center at Houston (UTHealth); Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth); Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth); Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth); (Neurology, v.102, 2024, pp.2447)
-
139
- P.6.c.006 Anxiety and depressive symptoms or disorders in patients with cannabis dependence without major psychiatric disorders
- Dervaux, A.; Krebs, M.O.; Laqueille, X.; ; (European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, v.21, 2011, pp.S578-S579)
-
140
- P.6.c.006 Anxiety and depressive symptoms or disorders in patients with cannabis dependence without major psychiatric disorders
- Dervaux, A.; Krebs, M. O.; Laqueille, X.; ; (European College of Neuropsychopharmacology, v.2011, 2011, pp.S578-S579)
QUICK MENU
